ArticleCureus2026
Obturator Foramen Bypass With Fluoroscopic Guidance for Recurrent Femoral Prosthetic Bypass Occlusions: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Repeated and additional prosthetic bypass to the femoral artery causes femoral crowding and adhesion and increases the risk of bypass infection. The femoral crowding may cause the stenosis of native and prosthetic bypass during hip flexion. An obturator foramen bypass is a bypass from a particular branch of the abdominal aorta to the lower limb artery to circumvent groin infection. This procedure is particularly effective in treating infected femoral prosthetic bypasses and mycotic femoral artery aneurysms; however, the bypass is routed through a narrow obturator foramen, which requires advanced technical skills. A 57-year-old Japanese man with a history of a coronary stent occlusion and a terminal aorta-left common femoral artery (CFA) prosthetic bypass occlusion underwent a right external iliac artery (EIA)-left superficial femoral artery (SFA) crossover prosthetic bypass. At the age of 61 years, the patient presented with pain in the left first toe with purulent discharge and noticed that the toe turned purple when his left hip joint was flexed during soaking in the bathtub. Contrast-enhanced computed tomography revealed occlusion of the right EIA-left SFA crossover prosthetic bypass and left narrow and shaggy CFA and SFA. Compression of the left CFA between the two occluded prosthetic bypasses and the caput femoris during hip flexion was considered to limit the blood flow to the lower limb, leading to chronic limb-threatening ischemia (CLTI). Those multiple femoral prosthetic bypasses had resulted in left femoral crowding, raising concerns that a new bypass to the left CFA might be compromised by the dynamic femoral compression during hip flexion. Therefore, an alternative bypass route was necessary. We successfully performed a 25-cm thrombectomy of the left femoral artery, followed by a right common iliac artery (CIA)-left SFA crossover prosthetic bypass through the left obturator foramen under live fluoroscopic guidance using Artis zeego (Siemens Healthineers, Erlangen, Germany). The postoperative course was uneventful. The graft remained patent over 12 months. Obturator foramen bypass may be considered an option not only in avoiding inguinal infections but also in addressing femoral crowding and compression caused by hip flexion. Penetrating the obturator foramen should be performed at the center or lower position. Preoperative vascular assessment of the foramen ovale on CT is also important. The procedure can be safely performed under live fluoroscopic guidance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.